CP-GEP Identifies High-Risk T1a Melanoma Patients Beyond Established Adverse Features

Wesley Y Yu; Ani Pazhava; Marie B Weitemeyer; Lisbet R Hölmich; Iva Johansson; Roger Olofsson Bagge; Jochen Utikal; Suraj Venna; Julie Jackson; Teresa Amaral; Alexander van Akkooi; Michael S Kolodney; Grant A McArthur; Alexander Meves

doi:10.1016/j.jaad.2025.10.036

CP-GEP Identifies High-Risk T1a Melanoma Patients Beyond Established Adverse Features

Wesley Y Yu
, Ani Pazhava
, Marie B Weitemeyer
, Lisbet R Hölmich
, Iva Johansson
, Roger Olofsson Bagge
, Jochen Utikal
, Suraj Venna
, Julie Jackson
, Teresa Amaral
, Alexander van Akkooi
, Michael S Kolodney
, Grant A McArthur
, Alexander Meves^*

^*Corresponding author for this work

Department of Plastic Surgery

1 Citation (Scopus)

Original language	English
Journal	Journal of the American Academy of Dermatology
Volume	94
Issue number	2
Pages (from-to)	661-663
Number of pages	3
ISSN	0190-9622
DOIs	https://doi.org/10.1016/j.jaad.2025.10.036
Publication status	Published - Feb 2026

Keywords

CP-GEP
melanoma
Merlin Assay
metastasis
risk prediction
sentinel lymph node biopsy

Access to Document

10.1016/j.jaad.2025.10.036Licence: CC BY

Cite this

Yu, W. Y., Pazhava, A., Weitemeyer, M. B., Hölmich, L. R., Johansson, I., Bagge, R. O., Utikal, J., Venna, S., Jackson, J., Amaral, T., van Akkooi, A., Kolodney, M. S., McArthur, G. A., & Meves, A. (2026). CP-GEP Identifies High-Risk T1a Melanoma Patients Beyond Established Adverse Features. Journal of the American Academy of Dermatology, 94(2), 661-663. https://doi.org/10.1016/j.jaad.2025.10.036

Yu, WY, Pazhava, A, Weitemeyer, MB , Hölmich, LR, Johansson, I, Bagge, RO, Utikal, J, Venna, S, Jackson, J, Amaral, T, van Akkooi, A, Kolodney, MS, McArthur, GA & Meves, A 2026, 'CP-GEP Identifies High-Risk T1a Melanoma Patients Beyond Established Adverse Features', Journal of the American Academy of Dermatology, vol. 94, no. 2, pp. 661-663. https://doi.org/10.1016/j.jaad.2025.10.036

@article{7b6a33bc85fc43fca4a28ee376104fae,

title = "CP-GEP Identifies High-Risk T1a Melanoma Patients Beyond Established Adverse Features",

keywords = "CP-GEP, melanoma, Merlin Assay, metastasis, risk prediction, sentinel lymph node biopsy",

author = "Yu, \{Wesley Y\} and Ani Pazhava and Weitemeyer, \{Marie B\} and H{\"o}lmich, \{Lisbet R\} and Iva Johansson and Bagge, \{Roger Olofsson\} and Jochen Utikal and Suraj Venna and Julie Jackson and Teresa Amaral and \{van Akkooi\}, Alexander and Kolodney, \{Michael S\} and McArthur, \{Grant A\} and Alexander Meves",

year = "2026",

month = feb,

doi = "10.1016/j.jaad.2025.10.036",

language = "English",

volume = "94",

pages = "661--663",

journal = "Journal of the American Academy of Dermatology",

issn = "0190-9622",

publisher = "Elsevier Inc.",

number = "2",

}

TY - JOUR

T1 - CP-GEP Identifies High-Risk T1a Melanoma Patients Beyond Established Adverse Features

AU - Yu, Wesley Y

AU - Pazhava, Ani

AU - Weitemeyer, Marie B

AU - Hölmich, Lisbet R

AU - Johansson, Iva

AU - Bagge, Roger Olofsson

AU - Utikal, Jochen

AU - Venna, Suraj

AU - Jackson, Julie

AU - Amaral, Teresa

AU - van Akkooi, Alexander

AU - Kolodney, Michael S

AU - McArthur, Grant A

AU - Meves, Alexander

PY - 2026/2

Y1 - 2026/2

KW - CP-GEP

KW - melanoma

KW - Merlin Assay

KW - metastasis

KW - risk prediction

KW - sentinel lymph node biopsy

UR - https://www.scopus.com/pages/publications/105025004550

U2 - 10.1016/j.jaad.2025.10.036

DO - 10.1016/j.jaad.2025.10.036

M3 - Journal article

C2 - 41093058

SN - 0190-9622

VL - 94

SP - 661

EP - 663

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

IS - 2

ER -

CP-GEP Identifies High-Risk T1a Melanoma Patients Beyond Established Adverse Features

Keywords

Access to Document

Other files and links

Cite this